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Abstract HIV screening studies in the emergency
department (ED) have demonstrated rates of HIV test
refusal ranging from 40–67%. This study aimed to deter-
mine the factors associated with refusal to undergo routine
rapid HIV testing in an academic ED in Boston. HIV
counselors offered routine testing to 1,959 patients; almost
one-third of patients (29%) refused. Data from a self-
administered survey were used to determine independent
correlates of HIV testing refusal. In multivariate analysis,
women and patients with annual household incomes of
$50,000 or more were more likely to refuse testing, as were
those who reported not engaging in HIV risk behaviors,
those previously HIV tested and those who did not perceive
a need for testing. Enrollment during morning hours was
also associated with an increased risk of refusal. Increased
educational efforts to convey the rationale and beneﬁts of
universal screening may improve testing uptake among
these groups.
Keywords Rapid HIV testing  HIV test refusal 
HIV test acceptance  Routine HIV testing  Emergency
department  Human immunodeﬁciency virus
Introduction
The Centers for Disease Control and Prevention (CDC)
estimate that 1 in 5 persons living with HIV infection in the
United States is unaware of his or her diagnosis, accounting
for more than 232,000 undiagnosed cases of HIV infection
[1]. To facilitate timely detection, the CDC revised their
HIV testing guidelines in 2006 to recommend routine HIV
testing in all health care settings, including emergency
departments (ED), for patients aged 13–64 years [2].
Despite these recommendations, in a survey of academic
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only 13% offered routine HIV screening [3]. As such, HIV
testing remains underutilized, with only 37% of US adults
having ever been tested for HIV [4].
As HIV infection is no longer conﬁned to traditional
high-risk groups [1], screening for HIV infection in ED
settings has the potential to extend testing to a broader
population, including heterosexual men and women, racial
and ethnic minorities, and socio-economically disadvan-
taged persons who may be more likely to seek care in an
ED setting [5–7]. EDs provide health care to persons at risk
of HIV infection in part due to either a lack of insurance or
a primary care physician. Many newly diagnosed HIV-
infected patients have had multiple encounters in ED set-
tings prior to diagnosis, representing ‘‘missed opportuni-
ties’’ for earlier detection [8, 9]. Previous studies of routine
voluntary HIV testing interventions in ED and urgent care
settings have been limited by test refusal rates as high as
40–67% [10–13]. While prior studies collected basic
demographic information and patients’ self-reported reason
for refusal [11–13], they did not, however, match reasons
for refusal in ED settings with patients’ reported HIV risk
factors to determine if risk perception and associated
refusal were appropriate.
A more thorough understanding of the factors underly-
ing HIV test refusal is critical as test refusers may in fact be
at a higher risk of HIV infection than those who accept [14,
15]. In this report, we aim to identify correlates of refusal
to undergo HIV testing in the ED. We hypothesized that
the patient-speciﬁc reasons for refusing testing are likely
multifactorial and potentially include access to an alter-
native regular source of care (and presumably to testing),
limited HIV-related knowledge, and a low perception of
risk and/or negative attitudes toward routine testing.
Methods
Parent Study
This study was conducted within the Universal Screening
for HIV-infection in the Emergency Room (USHER) trial,
funded by the National Institutes of Health; details of the
USHER trial have been published elsewhere [16–18]. The
parent study was conducted in the ED of Brigham and
Women’s Hospital, a tertiary academic medical center in
Boston, Massachusetts. This ED serves over 56,000
patients annually, 48% of whom are White, 25% are Black
and 20% Hispanic. Approximately 40% are men; the
median age is 44 years.
Patients were eligible to enroll in the USHER trial if
they were awaiting care in the ED when an HIV counselor
was available and were between the ages of 18–75 years,
English- or Spanish-speaking, and not known to be HIV
infected. Patients receiving prenatal care and those with an
altered mental status or an emergency severity index (ESI)
score of 1 or 2 (used as a surrogate for poor mental status or
increased acuity) were excluded from study participation.
The ﬁve-tiered ESI algorithm is employed at ED triage to
assess both patient acuity and the anticipated utilization of
ED resources––a score of 1 reﬂects the highest resource-
intensity and 5 the least [19]. Enrollment periods varied
weekly and spanned the hours between 8 am and 12 am,
Sunday through Saturday, for a minimum of 60 enrollment
hours per week.
Eligible patients were approached by a bilingual (Eng-
lish–Spanish) HIV counselor and invited to enroll in a trial
designed to learn more about HIV testing. Upon consent to
the trial, subjects were asked to complete a 20-min, 86-item
self-administered questionnaire. Subjects elected to com-
plete the questionnaire as either a pencil-and-paper version
or an audio computer-assisted self-interview (ACASI).
Both questionnaire modalities were administered in the
patient’s private room within the ED. Neither the HIV
counselors nor other ED study staff had access to the
results with the rare exception when a participant requested
assistance completing the questionnaire.
Enrolled subjects were randomized to rapid HIV test
offer by either an emergency provider or a dedicated HIV
counselor. During the 17-month trial period, 28 emergency
service (nursing) assistants (provider arm) and 9 USHER-
dedicated HIV counselors (counselor arm) were trained to
consent and test participants. Due to a low test offer rate in
the provider arm (36%) compared to the counselor arm
(80%) [18], we elected to examine correlates of refusal
only from the counselor arm to minimize concerns of
possible targeted test offer––with associated motivations to
accept––in the provider arm, based on HIV-related symp-
toms. Trial participants were offered a rapid oral HIV
antibody test (OraQuick
 Advance Rapid HIV-1/2 Anti-
body Test, OraSure Technologies, Bethlehem, Pennsylva-
nia) free of charge with conﬁrmation of reactive results as
previously described. Subjects who consented to rapid HIV
testing provided separate written informed consent for
rapid HIV testing in accordance with Massachusetts state
law. Trial participants were not offered any ﬁnancial
incentives. The USHER trial was approved by the Partners
Human Research Committee (protocol 2006P-000136) and
overseen by a Data Safety Monitoring Board.
Data Collection Instrument
Demographics and Access to Care
Demographic data (gender, age, race/ethnicity, primary
language and education level) were obtained at the time of
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123enrollment by the HIV counselor. The subjects’ chief
complaint and diagnosis were not recorded in trial-related
documents. The questionnaire collected self-reported
information on annual household income, medical insur-
ance status, access to a primary care provider, risk factor
assessment of substance abuse and sexual practices, HIV-
related knowledge, self-perceived need for HIV testing,
and HIV testing history. Annual household income was
reported as less than $20,000, $20–50,000, $50–100,000
and greater than $100,000 and, based on response distri-
bution, was categorized as less than $50,000 versus
$50,000 or more. Medical insurance status was obtained by
asking participants to indicate all sources of coverage from
the following options: Medicare, Medicaid, private and/or
other (‘‘insured’’) or uninsured. Participants were also
asked if they had a primary care provider (‘‘yes’’ versus
‘‘no’’ or ‘‘I don’t know’’).
HIV Risk Behaviors, HIV Knowledge, Perceived Need
for Testing and History of Prior Testing of Refusers
To examine the inﬂuence of HIV risk behaviors, partici-
pants were asked a series of questions regarding sexual
behaviors and frequency of illicit drug behavior or alcohol
use. We deﬁned sexual risk as report of any of the fol-
lowing: history of a sexually transmitted infection; two or
more sexual partners in the past year; any history of men
having sex with men; inconsistent or no condom use; his-
tory of incarceration; or sex with a partner who was known
to have been incarcerated, HIV infected or who used rec-
reational drugs.
Illicit drug use was deﬁned as report of any of the fol-
lowing: any history of injection drug use or a response of
‘‘occasionally’’ or more frequent use of marijuana, cocaine/
crack, amphetamines, crystal methamphetamine, alkyl
nitrites, LSD, ecstasy, heroin and/or oxycontin, or other
narcotics. Patients were asked to characterize their fre-
quency of use of these illicit substances as ‘‘never,’’
‘‘once,’’ ‘‘occasionally,’’ ‘‘monthly,’’ or ‘‘more than once
per month’’. Answering ‘‘once’’ to two or more drugs was
also considered illicit drug behavior.
Alcohol use was included in the assessment of HIV risk
behaviors because previous studies have demonstrated a
relationship between alcohol use disorders and sexual risk
behaviors [20, 21]. Alcohol risk behavior was deﬁned
according to the 10-question Alcohol Use Disorders Iden-
tiﬁcation Test (AUDIT) survey developed by the World
Health Organization; an AUDIT score of 8 or greater is
consistent with ‘‘hazardous and harmful’’ alcohol use [22].
Participants who reported at least one of these three risk
behaviors (sexual, illicit drug, alcohol) were categorized as
having an HIV risk behavior. Those who reported not
engaging in all queried risk factors were categorized as not
having any risk factors. Participants who reported no risk
factors but did not provide complete information for all risk
behaviors were categorized as ‘missing’.
Knowledge of HIV transmission and self-protective
behaviors was measured using the 18-item validated HIV
Knowledge Scale (HIV-KQ-18) [23]. HIV-related knowl-
edge scores were treated as a dichotomous variable, ‘‘high’’
(C17 correct items) versus ‘‘low’’ (B16 correct), based on
an a priori hypothesis that those with imperfect or ‘‘low’’
knowledge may be more likely to refuse HIV testing.
Sensitivity analyses were undertaken considering the HIV
knowledge score as a continuous variable. HIV testing
history was obtained by the following question: ‘‘Have you
ever been tested for HIV, the virus that causes AIDS?’’
Self-perceived need for HIV screening was deﬁned as
agreement (‘‘strongly agree’’ or ‘‘agree’’ versus ‘‘unde-
cided’’, ‘‘disagree’’ or ‘‘strongly disagree’’) with the state-
ment, ‘‘Based on my risk for HIV infection, I think I should
be HIV tested’’. We also examined whether enrollment day
(weekend vs. weekday) and time (8 am to 2 pm, 2 pm to
6 pm, 6 pm to 12am) were associated with refusal rates.
Statistical Analysis
TheoutcomeofinterestwasHIVtestingrefusal.Refusalrate
was deﬁned as the proportion of study participants who
refusedtoundergotestingamongthosewhowereenrolledin
the trial and offered HIV screening by an HIV counselor. As
refusal was relatively common, we used modiﬁed Poisson
regression with robust variance estimation to estimate the
relative risk (RR) as a measure of association for each risk
factor under consideration and risk of refusal [24].
A multivariate Poisson regression model was built to
identify independent correlates of higher refusal rates.
Inclusion of each covariate was based on either evidence
from prior studies, clinical judgment, author consensus or
having reached a provisional threshold for statistical sig-
niﬁcance in bivariate analysis (p\0.1). Factors included
in the multivariate model were gender, age, race/ethnicity,
education, annual household income, report of HIV risk
behaviors, level of HIV knowledge, history of prior testing,
perceived need for testing and time and day of enrollment.
Due to a high degree of collinearity with race/ethnicity,
language was excluded from the ﬁnal model. Items to
which study participants did not provide answers were
marked as a separate category noted as ‘missing’ and
interpreted as ‘‘lack of disclosure’’. In secondary analyses
we characterize correlates of refusal among participants
who perceived a need for HIV screening. Covariates that
reached a threshold p value of \0.1 on bivariate analysis
were advanced to a multivariate Poisson regression model.
All analyses were conducted using SAS software version
9.1.3 (SAS Institute, Cary, NC).
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Study Sample
Between February 2007 and June 2008, 12,970 ED patients
were screened for USHER trial eligibility based on age,
English/Spanish speaking and ESI score. Of the 8,187
eligible patients approached, 4,860 (59%) agreed to par-
ticipate in the USHER trial and 4,855 were randomized to
either the counselor (2,446) or provider (2,409) arms [18].
Eligible patients who refused trial enrollment were similar
in gender and ESI score distribution to trial participants;
trial enrollees were signiﬁcantly younger than those who
refused participation (37 vs. 43 years, p\0.0001).
Among the 1,959 subjects offered HIV testing by an
HIV counselor, 577 (29%) refused. Demographic charac-
teristics of these subjects are presented in Table 1. Women
represented 65% of our study sample. The median age was
35 years (interquartile range, 25–48 years) and 38% were
White, 21% were Black and 30% were Hispanic. About
one-quarter (27%) of participants did not speak English as
their primary language. Nearly two-thirds (64%) of par-
ticipants reported their educational attainment to be past
high school.
Demographic Characteristics and Access to Care
of Test Refusers
Bivariate analyses (Table 2) demonstrated that women
were more likely to refuse testing than men, as were per-
sons 30 years or older. Hispanic subjects and Spanish
speakers were less likely to refuse testing than Whites and
English speakers, respectively. Both educational attain-
ment greater than high school and an annual household
income of more than $50,000 were associated with
increased refusal. We did not ﬁnd an association between
HIV test refusal and access to care as deﬁned by insurance
status or having a primary care provider.
HIV Risk Behaviors, HIV Knowledge, History of Prior
Testing and Perceived Need for Testing of Refusers
Participants who did not report or disclose HIV risk
behaviors were more likely to refuse testing than those who
reported any HIV risk behavior. Nearly two-thirds of
refusers (367 of 577) had low HIV-related knowledge
scores; however, we did not ﬁnd a statistically signiﬁcant
or clinically meaningful association between HIV test
refusal and HIV knowledge in bivariate analysis. Results of
sensitivity analyses considering HIV knowledge score as a
continuous variable did not change our conclusions.
Of participants who perceived a need for testing, 14.9%
refused testing. Those participants who did not perceive a
need for testing as well as those who did not provide a
response regarding perception of need for testing were
more likely to refuse. Of note, among all subjects offered
testing who reported an HIV risk behavior, only 37.9%
perceived a need for testing. Among subjects who refused
testing and reported an HIV risk behavior, even fewer,
15.6%, perceived a need for testing.
Time of Enrollment
Participants enrolled in the morning hours (8 am–2 pm)
were more likely to refuse than evening (6 pm–12 am)
enrollees. A statistically signiﬁcant association between
HIV test refusal and day of enrollment (weekend vs.
weekday) was not detected in this sample.
Results of Multivariate Analyses
In multivariate analysis, women (RR = 1.23, 95% CI:
1.06–1.43) and participants with annual household incomes
Table 1 Demographics of subjects offered a rapid HIV test by an




Gender, n = 1951
Men 679 (34.8%)
Women 1272 (65.2%)

















Education, n = 1951
\High school 259 (13.3%)
High school 446 (22.9%)
[High school 1246 (63.9%)
a Percentages may total more than 100% due to rounding
b IQR––Interquartile range
c Due to small numbers, participants who identiﬁed themselves as
either Asian, Native-American, multiracial or other were all catego-
rized as Other
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123Table 2 Bivariate and multivariate analysis of correlates of refusal of rapid HIV screening
Characteristic Refused rapid HIV









Men 177 (26.1%) Reference
Women 398 (31.3%) 1.20 1.03–1.40 1.23 1.06–1.43
Age
c
18–29 183 (25.0%) Reference
30? 381 (32.1%) 1.28 1.10–1.49 1.11 0.95–1.29
Race/ethnicity
c
White 256 (34.4%) Reference
Black 127 (30.5%) 0.89 0.74–1.06 1.04 0.87–1.24
Hispanic 135 (23.1%) 0.67 0.56–0.80 0.86 0.70–1.05
Other 57 (28.8%) 0.84 0.66–1.06 0.89 0.70–1.13
Primary language
c
English 449 (31.7%) Reference
Spanish 94 (23.0%) 0.72 0. 60–0.88 ––
Other 31 (25.4%) 0.80 0.59–1.10 – –
Education
c
\High school 61 (23.6%) Reference
High school 117 (26.2%) 1.11 0.85–1.46 1.09 0.82–1.43
[High school 395 (31.7%) 1.35 1.07–1.70 1.09 0.84–1.40
Annual household income
\$50,000 191 (23.9%) Reference
C$50,000 179 (36.5%) 1.53 1.29–1.81 1.25 1.04–1.51
Missing 207 (30.9%) 1.29 1.09–1.53 1.13 0.86–1.47
Insurance status
Insured 386 (29.2%) Reference
Uninsured 16 (24.6%) 0.84 0.55–1.30 – –
Missing 175 (30.6%) 1.05 0.90–1.22 – –
Has a primary care provider
Yes 313 (28.4%) Reference
No/don’t know 70 (30.7%) 1.08 0.87–1.34 – –
Missing 194 (30.9%) 1.09 0.94–1.27 – –
HIV risk behavior
Present 289 (25.3%) Reference
None reported 66 (39.5%) 1.56 1.26–1.93 1.43 1.15–1.78
Missing 222 (34.1%) 1.35 1.16–1.56 1.59 1.23–2.06
HIV knowledge
High 97 (29.6%) Reference
Low 367 (30.5%) 1.03 0.85–1.24 1.14 0.94–1.38
Missing 113 (26.5%) 0.90 0.71–1.13 0.74 0.52–1.07
Prior HIV test
No prior HIV test 130 (28.3%) Reference
Prior HIV test 251 (28.0%) 0.99 0.83–1.19 1.20 1.01–1.44
Missing 196 (32.5%) 1.15 0.95–1.38 1.44 1.03–2.01
Perceived need for testing
Perceived need 93 (14.9%) Reference
No perceived need 364 (40.7%) 2.74 2.24–3.36 2.60 2.10–3.23
Missing 120 (27.3%) 1.84 1.44–2.34 1.57 1.11–2.22
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123of at least $50,000 (RR = 1.25, 95% CI: 1.04–1.51) were
more likely to refuse HIV testing (Table 2). Furthermore,
participants who reported engaging in no HIV risk behavior
had an increased risk of refusal (RR = 1.43, 95% CI:
1.15–1.78), as did those who did not completely disclose
their HIV risk behavior (RR = 1.59, 95% CI: 1.23–2.06).
Compared to those without a prior HIV testing history,
both those study participants who had been tested for HIV
previously (RR = 1.20, 95% CI: 1.01–1.44) and those who
did not provide any information regarding prior HIV test-
ing history (RR = 1.44, 95% CI: 1.03–2.01) were more
likely to refuse HIV testing. Patients who either did not
perceive a need for testing (RR = 2.60, 95% CI:
2.10–3.23) or whose response to a perceived need were
missing (RR = 1.57, 95% CI: 1.11–2.22) were also more
likely to refuse. Morning hours were associated with higher
rates of refusal (RR = 1.24, 95% CI: 1.03–1.49).
Correlates of Refusal Among Those With a Perceived
Need for Testing
Among the 1,959 subjects offered HIV testing by an HIV
counselor, 626 (32%) reported a perceived need for testing.
Bivariate analyses of those who perceived a need for
testing demonstrated the following signiﬁcant correlates of
refusal: age greater than 30 years; household income of
greater than $50,000; no HIV risk behaviors; low HIV
knowledge; prior HIV testing; and weekday enrollment.
Participants who did not report their insurance status were
less likely to refuse. In multivariate analysis, only subjects
who reported engaging in no HIV risk behaviors
(RR = 2.08, 95% CI: 1.08–3.97) and those who did not
disclose their HIV risk behavior (RR = 2.01, 95% CI:
1.03–3.93) were found to be more likely to refuse
(Table 3).
Table 2 continued
Characteristic Refused rapid HIV









Evening 6 pm–12am 119 (25.7%) Reference
Afternoon 2 pm–6 pm 203 (28.6%) 1.11 0.92–1.35 1.09 0.90–1.32
Morning 8am–2 pm 250 (32.3%) 1.26 1.04–1.51 1.24 1.03–1.49
Day of enrollment
c
Weekend 89 (25.7%) Reference
Weekday 486 (30.2%) 1.17 0.97–1.43 1.17 0.97–1.41
Bold values denote p\0.05
a Relative risk (RR)[1 indicates increased refusal of rapid HIV testing versus the reference group
b Conﬁdence Interval (CI)
c Due to missing values, gender, n = 575; age, n = 564; race/ethnicity, n = 575; primary language, n = 574; education, n = 573; time of
enrollment, n = 572; day of enrollment, n = 575
Table 3 Multivariate analysis of correlates of refusal of rapid HIV
screening among patients who perceived a need for HIV testing,
N = 626
Characteristic Refused rapid HIV





18–29 29 (11.4%) Reference
30? 63 (17.5%) 1.23 0.81–1.88
Annual household income
\$50,000 40 (11.2%) Reference
C$50,000 16 (15.7%) 1.46 0.83–2.55
Missing 37 (22.2%) 1.14 0.60–2.15
Insurance status
Insured 59 (12.6%) Reference
Uninsured 4 (9.8%) 0.86 0.34–2.18
Missing 30 (25.6%) 0.90 0.45–1.80
HIV risk behavior
Present 45 (10.4%) Reference
None reported 10 (20.8%) 2.08 1.08–3.97
Missing 38 (26.0%) 2.01 1.03–3.93
HIV knowledge
High 14 (14.6%) Reference
Low 64 (13.3%) 0.84 0.48–1.47
Missing 15 (30.0%) 1.27 0.60–2.71
Prior HIV test
No prior HIV test 10 (7.5%) Reference
Prior HIV test 46 (13.0%) 1.77 0.92–3.42
Missing 37 (27.0%) 2.09 0.77–5.69
Day of enrollment
Weekend 11 (9.4%) Reference
Weekday 82 (16.1%) 1.73 0.95–3.12
Bold values denote p\0.05
a Due to missing values, age, n = 92
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Within the context of the USHER trial, 29% of the 1,959
patients who were offered a rapid HIV test in the emer-
gency department by an HIV counselor refused the test.
This rate of refusal is comparable to the experience of other
ED studies [10–13]. Despite the overall success of routine
HIV testing programs, we identiﬁed women and partici-
pants with annual household incomes of $50,000 or greater
to be more likely to refuse testing, as well as those who
reported no HIV risk behaviors, those previously tested for
HIV, those who did not perceive a need for testing and
participants enrolled during morning hours.
Complex factors including lack of social support and
fear of stigma or rejection if HIV-infected may underlie the
identiﬁed greater tendency of women to refuse testing [25].
Although women have the highest rate of lifetime HIV
testing, much of this testing is performed in the context of
prenatal care [26]. Women infected through heterosexual
contact represent an increasing proportion of HIV infection
in the U.S, underscoring the clinical relevance of our
ﬁnding [27]. Low risk-perception has been postulated as a
possible explanation for this rise in diagnosed infection
among women [28] and this misperception may be shared
by health care providers who may be less likely to offer
HIV testing to women [9].
We also identiﬁed a signiﬁcant association between
higher incomes and increased HIV test refusal. This asso-
ciation has not been previously described; prior studies of
routine ED HIV testing have not included income in their
analysis [10, 29]. Higher income, however, has been cor-
related with having been previously tested in a study of
rapid HIV testing among men who have sex with men
frequenting bathhouses in New York [30]. Differences in
the motivation for testing in a risk-taking venue versus an
ED screening study may account for these observations.
Consistent with the results of National Health Interview
Surveys, we also found that patients who reported not
engaging in HIV risk behaviors were more likely to refuse
than those who reported any HIV risk behavior [26].
Patients who did not disclose their HIV risk behaviors were
also more likely to refuse. We do not have HIV sero-
prevalence data from this sample to determine if those who
refused are indeed infected or have unreported HIV risk
behaviors. In addition, we did not observe a signiﬁcant
association of test refusal with a low score on the HIV
knowledge scale to suggest that a poor understanding of
HIV transmission motivates test refusal.
After adjusting for other factors, we found a history of
prior HIV testing to be associated with a 20% increase in
HIV test refusal. Refusal for these participants may simply
be related to close temporal proximity to their most recent
test [2]; however, we are unable to corroborate dates of
self-reported prior testing. Having been tested is a com-
monly cited reason for HIV test refusal [11, 31]. Dietz et al.
demonstrated that patients who were tested only once in the
past were more likely to refuse subsequent testing com-
pared to patients who provided a history of multiple prior
HIV tests [31]. Kalichman and Cain found that patients
who were repeatedly HIV tested, as well as those who
refused testing, had risk behaviors that placed them at
higher risk for HIV infection compared to patients tested
only once [32]. Perceived risk for HIV infection may
underlie this behavior as patients who maintain a high
perception of risk pursue repeat testing while those with a
low perception of risk refuse subsequent testing, regardless
of their actual risk. While in this study we did not specif-
ically ask about HIV risk perception, but rather a self-
perceived need for a test, we found that a low self-per-
ceived need for testing was the strongest independent
correlate for test refusal, with over a two-fold increased
risk.
Perception of risk may be inﬂuenced by non-clinical
factors [33, 34] and is frequently discordant from actual
risk [14, 35, 36]. This is supported by our observation that
among patients who both reported an HIV risk behavior
and refused testing, the proportion who perceived a need
for testing was quite low (16%). In addition, nearly 15% of
patients in our study who perceived a need for testing based
on their risk of infection ultimately refused testing. In a
secondary analysis restricted to participants self-reporting a
perceived need for testing, we found increased refusal to be
associated with either report of no HIV risk behaviors or
lack of disclosure regarding HIV risk behaviors. While this
difference in perception and action may be a product of
competing interests such as clinical evaluation and care, it
remains concerning and discrepancies in actual HIV testing
rates relative to a statement of intent or plan to undergo
testing have been previously described [26].
We also found that the patients enrolled in the morning
were more likely to refuse testing than evening enrollees, a
ﬁnding not observed by Merchant et al. in their analysis of
a random sample of ED patients offered screening [13].
Other studies of routine rapid HIV testing in ED settings
which may have provided information regarding patient
receptiveness to testing by time of offer enrolled during
limited day and evening hours and did not examine the
association of test refusal with time of enrollment [10, 12,
29]. Many counselor-based programs and traditional ven-
ues for voluntary counseling and testing (VCT) operate
during regular work-day hours, a schedule that may not
maximize participation with routine testing. Our ﬁndings
suggest that time of test offer affects the rate of refusal. The
allocation of resources for ED HIV testing efforts may be
optimized by focusing on higher yield times of test
acceptance.
740 AIDS Behav (2011) 15:734–742
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This study was subject to several limitations. The USHER
trial was conducted at a single site, and our results may not
be generalizable to other EDs. The experience of our study
site may be similar, however, to those of other busy urban
academic emergency departments offering routine opt-in
HIV testing. The rate of test refusal in the USHER trial
may be conservative as ED patients more likely to refuse
HIV testing may have declined initial trial participation.
However, patients enrolling in the trial were demographi-
cally similar to those who refused, with the exception of
age; we did not identify age as a correlate of refusal.
Other factors that may be potentially associated with
refusal of HIV testing were not assessed in this study and,
as in all survey studies, it is possible that some of our
measures lacked precision, potentially resulting in residual
confounding despite adjustment. For example, sexual risk
behaviors were limited to reports of a high risk partner,
prior sexually transmitted infections, and frequency of
condom use. Other sexual risk behaviors associated with
HIV infection––such as heterosexual anal intercourse—
were not speciﬁcally queried. Such information may have
helped to inform the relationship among HIV test refusal,
sexual preference and gender.
Data regarding the chief complaint or diagnoses were
not collected, nor was information on length of ED visit.
Racial concordance between the person offering an HIV
test and the subject has previously been found to inﬂuence
test acceptance [37]. In this study, however, provider/
counselor-level factors such as speciﬁc person offering the
test, or racial and gender concordance could not be eval-
uated as the identity of the HIV counselor enrolling,
counseling and testing the patient was only recorded if the
participant both accepted and underwent testing. Addi-
tionally, low test offer rates in the provider arm limited our
capacity to address correlates of HIV testing refusal when
offered speciﬁcally by an ED provider.
This study is also susceptible to both social desirability
bias and non-response bias as our survey instrument que-
ried sensitive and potentially stigmatizing information. In
an attempt to optimize data collection, we offered partici-
pants a choice between two different modes of completing
a self-administered questionnaire although only 11% of
respondents utilized the ACASI [38]. We also included in
the analyses participants who either deliberately or inad-
vertently did not disclose information. We did note pro-
gressive attrition of responses to items encountered later in
the questionnaire. The ﬁnal 16 items referred to alcohol
and illicit drug use, and we maintained a conservative
deﬁnition of risk (i.e. the report of any risk behavior) in
part to accommodate these missing responses.
Furthermore, in accordance with Massachusetts state
law, separate written informed consent forms were required
for both USHER trial enrollment and for HIV screening.
The need for multiple consent processes may have limited
study participation and the generalizability of our ﬁndings.
Despite these limitations, the design of the USHER trial
offered a unique opportunity to examine correlates of
refusal. Many prior routine screening studies were unable
to do so as once patients refused HIV testing no further
data were collected.
Conclusions
While current CDC guidelines recommend universal
screening, our ﬁndings demonstrate that routine HIV
screening programs may not fully or equally engage all
groups including women, patients with higher incomes and
participants who did not perceive a need for HIV testing.
Increased educational efforts to convey the rationale and
beneﬁts of universal screening may improve testing uptake
among these groups. In addition, the modiﬁcation of rou-
tine HIV screening programs to offer testing during hours
of lower test refusal may increase testing rates.
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